Pancreatic cancer cells express excessive amounts of a cell receptor known as the RON receptor tyrosine kinase, a finding that has potential implications for treatment, according to a research team led by University of Cincinnati scientists (Thomas RM et al. Cancer Research. http://cancerres.aacrjournals.org/ [published online ahead of print July 1, 2007]). Overall survival for pancreatic cancer is only about 4%, according to the National Cancer Institute, at least in part because the disease spreads before it can be detected.
Hampton T. Pancreatic Cancer Protein. JAMA. 2007;298(5):505. doi:10.1001/jama.298.5.505-a